Table 1

Baseline characteristics among incident CVD cases and matched controls
Incident cases Controls P value
Number 211 633 NA
Age, years 60 60 NA
Male gender, % 66.4 66.4 NA
Smokers, % 31.9 19.6 0.0002
Diabetes % 24.3 15.7 0.005
BMI kg/m2 27.7 ±4.6 26.7 ±3.8 0.0031
Hypertension (>140/90 mm Hg ), % 42.4 25.6 <0.0001
Glucose mmol/L 6.1 ±2.5 5.6 ±1.5 0.0004
Insulin μmol/L 11.4 ±7.1 10.2±6.5 0.0317
Systolic blood pressure, mm Hg 148 ±21.8 139 ±21.2 <0.0001
Diastolic blood pressure, mm Hg 98 ±10.6 85 ± 10.4 <0.0001
Cholesterol, mMol/l 6.1 ±1.0 6.0 ±1.2 0.14
HDL, mMol/l 1.3 ±0.4 1.4 ±0.4 0.0005
LDL, mMol/l 3.9 ±1.2 3.8 ±1.1 0.45
Triglycerides, mMol/l 1.6 ±1.0 1.4 ±0.8 0.0005
hsCRP, mg/l 2.4 (1.3-4.7) 1.7(0.9-3.2) <.0001
eGFR 90.5 (81.4-106.0) 90.9 (80.4-103.9) 0.73
Framingham Risk Score 14.5±2.3 13.5±2.0 <0.0001
IgM anti-OxCL U/ml, men and women. 88.97(68.36-114.6) 96.90(72.56-123.44) 0.024
IgM anti-OxCL U/ml , men. 84.16(63.38-112.57) 96.90(70.35-123.10) 0.0047
IgM anti-OxCL U/ml , women. 99.06(78.04-123.70) 96.75(74.07-124.37) 0.78
IgM anti-CL U/ml, men and women. 1.87(1.34-3.00) 2.02(1.38-3.12) 0.34

Data are presented as percentage, mean ± SD, or median with interquartile ranges within paranthesis.

Su et al.

Su et al. BMC Cardiovascular Disorders 2013 13:1   doi:10.1186/1471-2261-13-1

Open Data